2023 Brokerage Ratings for Reckitt Benckiser Group plc: Average Rating of “Hold”

March 25, 2023

Trending News 🌥️

Reckitt Benckiser ($LSE:RKT) Group plc, a leading global consumer goods company, has received an average rating of “Hold” from brokerages in 2023. This is based on a number of factors, including the company’s stock performance, business strategies, and competitive environment. The Hold rating reflects analysts’ views that Reckitt Benckiser Group plc is unlikely to outperform the broader market in the near term. This is partially due to the company’s mixed financial performance in recent quarters and the uncertain macroeconomic conditions in many of its key markets. Some analysts also remain concerned about the company’s ability to achieve its ambitious growth targets in the coming years.

However, some analysts are more optimistic about Reckitt Benckiser Group plc’s long-term prospects. They point to several positive factors, including the company’s strong portfolio of well-established brands, its track record of successful acquisitions, and its established presence in many lucrative emerging markets. Overall, the Hold rating given to Reckitt Benckiser Group plc by brokerages based on their 2023 analysis reflects a cautious outlook for the company in the short term, but with potential for long-term growth.

Market Price

Reckitt Benckiser Group plc has recently been receiving mostly positive news sentiment. This is evidenced by the fact that on Friday, the stock opened at £59.8 and closed at £61.0, representing a 2.0% increase from the previous closing price of 59.8. Currently, the averaged broker rating for Reckitt Benckiser Group plc is “Hold”. This means that analysts are not recommending investors to buy or sell the stock at this time. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Reckitt Benckiser. More…

    Total Revenues Net Income Net Margin
    14.45k 2.33k 16.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Reckitt Benckiser. More…

    Operations Investing Financing
    2.4k -139 -2.38k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Reckitt Benckiser. More…

    Total Assets Total Liabilities Book Value Per Share
    28.74k 19.26k 12.47
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Reckitt Benckiser are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    4.0% -0.5% 23.0%
    FCF Margin ROE ROA
    13.5% 22.6% 7.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    As part of our analysis of Reckitt Benckiser‘s fundamentals, we at GoodWhale have been using the Star Chart to assess the company’s strengths and weaknesses. According to our results, Reckitt Benckiser is particularly strong in terms of dividends and profitability, but is only medium in terms of growth. In terms of assets, however, it is weak. We have also assessed Reckitt Benckiser’s health score, which comes in at an impressive 8/10. This suggests that the company is in a strong financial position, and is likely capable of weathering any kind of crisis without the risk of bankruptcy. Finally, we have classified Reckitt Benckiser as a ‘rhino’, meaning that it has achieved moderate revenue or earnings growth. Investors looking for steady, solid returns may be interested in such companies, as they present lower risk and potentially greater rewards than more growth-orientated stocks. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis


  • Peers

    It is one of the world’s leading consumer goods companies and is in direct competition with other major players such as Anagenics Ltd, Halo Food Co Ltd, and Hindustan Unilever Ltd. All four companies have a strong presence in the global market and are continuously striving to provide customers with the best products and services.

    – Anagenics Ltd ($ASX:AN1)

    Anagenics Ltd is a biotechnology company that specializes in the research and development of novel therapeutics to treat neurological disorders. With a market cap of 5.53M as of 2022, the company is relatively small when compared to its competitors. Despite this, Anagenics Ltd has produced a negative return on equity of -23.53%, indicating that the company’s shareholders are not benefitting from their investment. This low ROE could be due to several factors, such as the company not having sufficient profits or the company being in a highly competitive market.

    – Halo Food Co Ltd ($ASX:HLF)

    Halo Food Co Ltd is a food processing and distribution company based in Manchester, England. The company has been in business since 1887 and is known for its high-quality products. The company has a market cap of 11.22M as of 2022, which suggests that it has a moderate level of market capitalization. This indicates that the company has some financial strength, but is not considered a major player in the industry. Additionally, the Return on Equity (ROE) of the company is -11.05%, which suggests that the company is not generating a significant return on its equity. This could indicate that the company may have difficulty generating sufficient profits to cover its expenses.

    – Hindustan Unilever Ltd ($BSE:500696)

    Hindustan Unilever Ltd is an Indian consumer goods company with a market cap of 6.07T as of 2022. It is one of the biggest companies in India and is a subsidiary of Unilever, the Anglo-Dutch consumer goods company. The company has a Return on Equity (ROE) of 16.24%, which is an indication of its strong financial performance. Hindustan Unilever produces a wide range of products in the areas of food and beverages, personal care, home care, and water purification. It also has a strong presence in the emerging markets of India and South Asia, with a wide network of distributors and retailers.

    Summary

    Reckitt Benckiser Group plc is currently rated as a “Hold” by most major brokerages. Despite the average recommendation, investors should consider the overall sentiment towards the company which has been mostly positive right now. A thorough analysis of the firm’s financials should be conducted to determine if the company’s stock is a viable investment opportunity. It is important to analyze the company’s fundamentals, such as its earnings and revenue growth, as well as its balance sheet and cash flow to assess if it has the potential to be profitable.

    Additionally, investors should take into account any recent news or announcements from the company in relation to product launches, management changes and strategic partnerships which may affect their stock price. Ultimately, investing in Reckitt Benckiser Group plc is a decision that should be taken with careful consideration and research.

    Recent Posts

    Leave a Comment